Ultrasonic Aspirator - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The ultrasonic aspirator market size was valued at USD 210.24 million in 2025 and is estimated to grow from USD 225.61 million in 2026 to reach USD 331.95 million by 2031, at a CAGR of 8.03% during the forecast period (2026-2031). This report is Segmented by Product (Integrated, Standalone), Application (Neurosurgery, Gynecological, Gastrointestinal, Cardiac, Orthodontic Surgery, Brain Cancers, Ischemic Stroke, TBI, Other), End-User (Hospitals, Ascs, Specialty Clinics, Other), and Geography (North America, Europe, Asia-Pacific, MEA, South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Ultrasonic Aspirator Market Trends and Insights

Rising Neurological And Oncology Surgery Volumes

The ultrasonic aspirator market continues to draw durable support from rising neurological and oncology surgery volumes because the core use case remains tied to delicate tissue removal around critical neural structures. This demand is directly related to the growing disease burden, and global brain and central nervous system cancer prevalence reached 975,279 cases in 2021, with the age-standardized prevalence rate projected to increase from 12 to 13.5 per 100,000 by 2040.The ultrasonic aspirator market also benefits when complex tumor surgeries become more concentrated at tertiary centers, because those centers are more likely to purchase premium systems, maintain trained teams, and standardize workflows around established platforms. That concentration creates a smaller but more predictable customer base for the ultrasonic aspirator market, and it improves visibility for service contracts, disposable demand, and account expansion after the first console sale. It also raises the value of vendor-led training and clinical support, since hospitals that handle higher-acuity caseloads tend to expect stronger procedural coverage and faster troubleshooting. As a result, disease burden not only increases procedure counts in the ultrasonic aspirator market, but it also improves the commercial quality of demand inside the most important buying accounts.

Shift Toward Precision-Based Minimally Invasive Surgery

The ultrasonic aspirator market is also being lifted by the move toward precision-based minimally invasive surgery, where surgeons need selective tissue fragmentation in tighter spaces and near vulnerable vessels or nerves. The evidence for laparoscopic endometriosis excision, where investigators reported safe use of CUSA with limited thermal spread in fertility-preserving procedures. A separate 2025 simulation study also supported the safety profile of ultrasonic aspiration in intramedullary spinal cord tumor treatment by showing operating temperatures remained below the 46 °C tissue-necrosis threshold. That matters for the ultrasonic aspirator market because minimally invasive adoption does not simply shift existing case volume from one tool to another; it expands the number of procedures where aspirators can be justified on precision and tissue-preservation grounds. The ultrasonic aspirator market also gains from cross-specialty use, since one installed console can support neurosurgery, liver resection, gynecological surgery, thoracic surgery, and now selected cardiac procedures when the system holds the right clearances. This pattern strengthens platform economics for hospitals and reinforces the role of multifunction consoles in the ultrasonic aspirator market.

High Capital And Lifecycle Ownership Cost

High capital and lifecycle ownership costs remain one of the clearest limits on the ultrasonic aspirator market because the full expense reaches well beyond the base console purchase. The ownership includes service agreements, replacement handpieces and tips, consumables, and formal training, which makes the economic decision more difficult for smaller hospitals and focused outpatient centers. This issue matters across the ultrasonic aspirator market because adoption often depends on committee review, and committees tend to compare aspirators against other energy platforms that appear easier to justify on immediate utilization. Cost pressure is also more visible in channels where case volume is still building, since facilities may struggle to spread fixed service and training costs over enough procedures in the early years of adoption. In practical terms, the ultrasonic aspirator market expands faster when vendors offer flexible financing, refurbished platforms, longer warranties, or simpler recurring-cost models that reduce budget friction at the account level. Without that adaptation, some customers will continue to delay purchase decisions even when clinical demand is present.

Other drivers and restraints analyzed in the detailed report include:

• AI-Guided Surgical Workflow Integration
• Expansion Of Ambulatory And Day-Surgery Capacity
• Shortage Of Surgeons and or Staff Trained On Ultrasonic Tissue Fragmentation

Segment Analysis

Integrated systems held 61.31% share of the ultrasonic aspirator market size in 2025, and they are also projected to expand at an 8.68% CAGR through 2031. This leadership reflects buyer preference for consolidated platforms that combine power delivery, aspiration, irrigation, and handpiece control inside a single console, which lowers compatibility risk and makes operating room setup more predictable. Integra's CUSA Clarity is a clear example of that model, and its indication expansion into cardiac surgery in November 2025 showed how one installed platform can keep adding procedural value over time. Stryker's Sonopet iQ also supports this integrated direction, since its 2025 clearance added real-time modulation and wireless foot control features that fit academic and high-precision settings. The ultrasonic aspirator market, therefore, favors integrated systems not only because they simplify console management, but also because they create a better base for multi-specialty use, training standardization, and hospital-wide service support.

Standalone systems remain relevant in the ultrasonic aspirator industry because they serve hospitals and specialist centers that want to upgrade handpieces or preserve existing infrastructure without replacing the full console. Growth in this part of the ultrasonic aspirator market is slower, but the slower pace reflects replacement timing rather than disappearing need. Mature sites in North America and Europe still operate legacy equipment, and that installed base preserves a practical role for stepwise upgrades instead of immediate conversion to a new integrated platform. The regulatory framework also keeps both product types active, because ultrasonic surgical devices under FDA product code LFL and 21 CFR Part 878 still need to demonstrate substantial equivalence through the 510(k) route, regardless of configuration. Over the medium term, the ultrasonic aspirator industry is likely to keep integrated systems in the lead while allowing standalone systems to hold a narrower but still durable replacement-oriented niche.

Complete Report Scope:

• By Product
  • Integrated
  • Standalone
• By Application
  • Neurosurgery
  • Gynecological Surgery
  • Gastrointestinal Surgery
  • Cardiac Surgery
  • Orthodontic Surgery
  • Brain Cancers
  • Ischemic Stroke
  • Traumatic Brain Injury
  • Other Applications
• By End-User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Other End-Users
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America held 38.16% ultrasonic aspirator market share in 2025, which made it the largest regional contributor to the ultrasonic aspirator market. The region benefits from a dense concentration of academic neurosurgery centers, higher procedure intensity, and an FDA pathway that allows suppliers to expand indications and refresh product features with relatively consistent regulatory logic. The ultrasonic aspirator market in North America also gains from mature installed bases, because replacement demand from legacy systems can support recurring capital cycles even when first-time adoption moderates. Medtronic's broad neurosurgery platform presence strengthens this regional position further by giving the company a practical route to cross-sell aspiration tools into already established navigation and imaging accounts.

Europe remains a major pillar of the ultrasonic aspirator market because it combines long-standing academic neurosurgery capability with a high underlying disease burden in neuro-oncology. Western Europe recorded the world's highest brain and central nervous system cancer age-standardized incidence rate at 7.4 per 100,000, which supports a steady procedural need for ultrasonic aspiration. Germany stands out through both demand and device manufacturing depth, while the United Kingdom and France remain important treatment centers with established hospital networks. The ultrasonic aspirator market in Europe is therefore supported by clinical capability and structural demand, even though procurement and compliance processes can remain slower than in the United States.

Asia-Pacific is projected to expand at 9.96% CAGR through 2031, which makes it the fastest-growing regional portion of the ultrasonic aspirator market size. Japan contributes through a large neurosurgical need base, and the high-income Asia-Pacific cohort recorded a brain and central nervous system cancer age-standardized prevalence rate of 36.4 per 100,000. China adds a different growth pattern, with hospital modernization and device localization shaping how the ultrasonic aspirator market develops across large care networks. The Middle East and Africa and South America remain smaller parts of the ultrasonic aspirator market, with growth concentrated in better-funded health systems and major urban hospitals. These regions still offer room for expansion, but distributor dependence, training limitations, and longer approval pathways can slow the speed of adoption compared with North America, Europe, and advanced Asia-Pacific markets.

List of Companies Covered in this Report:

• B. Braun
• Biomedicon Systems India Pvt Ltd
• Bioventus Inc.
• Boston Scientific
• BOWA Medical
• Conmed
• Innosurge
• Integra LifeSciences
• Johnson & Johnson
• Karl Storz
• Medtronic
• Mectron S.p.A.
• META Dynamic, Inc.
• Nakanishi
• Olympus
• Richard Wolf
• Söring GmbH
• Stryker
• Toshbro Medicals Pvt. Ltd.
• Xcellance Medical Technologies

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support